日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of Composites Comprising Spherical, Porous, Sintered β-Tricalcium Phosphate Particles and Cyanoacrylate as Bone Cement

评价由球形多孔烧结β-磷酸三钙颗粒和氰基丙烯酸酯组成的复合材料作为骨水泥的性能

Hashimoto, Kazuaki; Aida, Shuhei; Takigawa, Iori; Shibata, Hirobumi; Kobune, Satoshi; Konishi, Toshiisa; Meguro, Takashi; Fukuyama, Shigeo; Tanaka, Shinya

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort

基于对前瞻性多中心队列的回顾性分析,简化日本慢性丙型肝炎患者索非布韦/维帕他韦的监测

Suda, Goki; Baba, Masaru; Yamamoto, Yoshiya; Yoshida, Sonoe; Muranaka, Tetsuhito; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Kobayashi, Tomoe; Izumi, Takaaki; Takagi, Tomofumi; Hosoda, Shunichi; Yamada, Ren; Fu, Qingjie; Yang, Zijian; Yokoyama, Daisuke; Tanaka, Takatsugu; Meno, Akimitsu; Yasuura, Naohiro; Kitagataya, Takashi; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.

基线 CXCL9 水平低可预测接受 Atezolizumab 联合 Bevacizumab 治疗的不可切除 HCC 患者的早期疾病进展

Hosoda Shunichi, Suda Goki, Sho Takuya, Ogawa Koji, Kimura Megumi, Yang Zijian, Yoshida Sonoe, Kubo Akinori, Tokuchi Yoshimasa, Kitagataya Takashi, Maehara Osamu, Ohnishi Shunsuke, Nakamura Akihisa, Yamada Ren, Ohara Masatsugu, Kawagishi Naoki, Natsuizaka Mitsuteru, Nakai Masato, Morikawa Kenichi, Furuya Ken, Baba Masaru, Yamamoto Yoshiya, Suzuki Kazuharu, Izumi Takaaki, Meguro Takashi, Terashita Katsumi, Ito Jun, Miyagishima Takuto, Sakamoto Naoya

A rare case of pancreatic ductal adenocarcinoma with ossification mimicking a pancreatic stone impaction

一例罕见的胰腺导管腺癌伴骨化,临床表现酷似胰腺结石嵌顿

Sugiura, Ryo; Sasaki, Kiyotaka; Nakamura, Hideaki; Horita, Shoichi; Meguro, Takashi; Kagaya, Hidetoshi; Yoshida, Tatsuya; Aoki, Hironori; Morita, Takayuki; Fujita, Miyoshi; Okamura, Keisuke; Tamoto, Eiji; Fukushima, Masayuki; Ueno, Takashi; Tsutaho, Akio; Inoue, Ayano; Takahashi, Toshiyuki

A rare case of pancreatic acinar cell carcinoma presenting a submucosal tumor

一例罕见的胰腺腺泡细胞癌,表现为黏膜下肿瘤。

Sugiura, Ryo; Kagaya, Hidetoshi; Nakamura, Hideaki; Horita, Shoichi; Meguro, Takashi; Sasaki, Kiyotaka; Yoshida, Tatsuya; Aoki, Hironori; Kuwatani, Masaki; Fukushima, Masayuki; Morita, Takayuki; Fujita, Miyoshi; Okamura, Keisuke; Tamoto, Eiji; Ueno, Takashi; Tsutaho, Akio; Inoue, Ayano; Takahashi, Toshiyuki

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150

阿特珠单抗和贝伐珠单抗治疗不符合 IMbrave150 研究入组标准的不可切除肝细胞癌患者的疗效及对肝功能储备的影响

Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya

Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603

雷莫芦单抗联合伊立替康治疗晚期胃癌患者二线治疗的II期研究:HGCSG1603

Kawamoto, Yasuyuki; Yuki, Satoshi; Sawada, Kentaro; Nakamura, Michio; Muto, Osamu; Sogabe, Susumu; Shindo, Yoshiaki; Ishiguro, Atsushi; Sato, Atsushi; Tsuji, Yasushi; Dazai, Masayoshi; Okuda, Hiroyuki; Meguro, Takashi; Harada, Kazuaki; Sekiguchi, Mari; Okada, Kazufumi; Ito, Yoichi M; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito

Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)

曲妥珠单抗联合伊立替康治疗既往接受过曲妥珠单抗治疗的 HER2 阳性胃癌患者的 II 期研究 (HGCSG 1201)

Kawamoto, Yasuyuki; Yuki, Satoshi; Meguro, Takashi; Hatanaka, Kazuteru; Uebayashi, Minoru; Nakamura, Michio; Okuda, Hiroyuki; Iwanaga, Ichiro; Kato, Takashi; Nakano, Shintaro; Sato, Atsushi; Harada, Kazuaki; Oba, Koji; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito

Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies

HGCSG1801 研究方案:一项多中心、前瞻性 II 期临床试验,旨在评估二线 FOLFIRI 联合阿柏西普治疗对 EGFR 抗体耐药的转移性结直肠癌患者的疗效。

Nakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, Yu

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting

在真实世界中,乐伐替尼治疗晚期肝细胞癌患者的早期疗效和安全性

Sho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, Naoya